tlooto
Sign up
Medicine

Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice

M. Kolář, D. Ďuricová, M. Bortlík, K. Pudilova, V. Hrubá, N. Machková, K. Mitrová, K. Malíčková, M. Lukas, M. Vašátko, R. Vaníčková, M. Lukáš

2019.2.28Gastroenterologie a Hepatologie

DOI: 10.14735/amgh201925

Abstract

Abstract is not available.

Citation format

KOLÁŘ, M., et al. Vedolizumab vs. ustekinumab as second-line therapy in crohn’s disease in clinical practice. Gastroenterologie a Hepatologie, 2019.